Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|December 19, 2013
Rationale for stereotactic body radiation therapy in treating patients with oligometastatic hormone-naïve prostate cancerOnita Bhattasali, Leonard N Chen, Michael Tong, et al.
Frontiers in Oncology|January 25, 2021
Utilization of Iodinated SpaceOAR Vue™ During Robotic Prostate Stereotactic Body Radiation Therapy (SBRT) to Identify the Rectal-Prostate Interface and Spare the Rectum: A Case ReportDylan Conroy, Kelly Becht, Matthew Forsthoefel, et al.
Frontiers in Oncology|September 22, 2015
Urethrogram-Directed Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Patients with Contraindications to Magnetic Resonance ImagingIma Paydar, Brian S Kim, Robyn A Cyr, et al.
Frontiers in Oncology|September 27, 2018
Long-Term Outcomes Following Conventionally Fractionated Stereotactic Boost for High-Grade Gliomas in Close Proximity to Critical Organs at RiskMichael C Repka, Siyuan Lei, Lloyd Campbell, et al.
Frontiers in Oncology|July 29, 2020
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer in Men With a High Baseline International Prostate Symptom Score (IPSS ≥ 15)Nima Aghdam, Abigail Pepin, David Buchberger, et al.
Cureus|August 24, 2016
The Impact of Obesity on Patient Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate CancerHarsha Koneru, Robyn Cyr, Li Rebekah Feng, et al.
Cureus|July 1, 2024
Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Men With Hip Prostheses: A Cautionary NoteSarthak Shah, Sanjeev Saravanakumar, Dylan Conroy, et al.
Frontiers in Oncology|June 1, 2016
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose ReductionMichael C Repka, Shan Guleria, Robyn A Cyr, et al.
Frontiers in Oncology|April 8, 2024
Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancerMichael C Repka, Tamir Sholklapper, Alan L Zwart, et al.
Radiation Oncology (London, England)|April 19, 2015
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancerMarie K Gurka, Leonard N Chen, Aditi Bhagat, et al.
Pageof 8